drugset / Trial / NCT01522677
A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
Phase 1/2
Withdrawn
Edward Nelson
National Cancer Institute (NCI) · collabUniversity of California, Irvine · collab
NaSingle-groupOpen-labelTreatment
Summary
The central hypothesis for this study is that it is safe and feasible to administer intraluminal photodynamic therapy (PDT) to colon cancers by colonoscopy to induce localized inflammatory/immune response. The objective is to demonstrate the feasibility and safety of PDT to colon cancer patients administered before surgery and to characterize the inflammatory/immune response at the tumor site and systemically. The long-term objective of these studies is to modify he natural biology of colorectal cancers and improve patient survival.
Timeline
- Start
- 2012-08
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | — | — |